Filing Details

Accession Number:
0000315066-14-001657
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-05 18:59:13
Reporting Period:
2014-01-30
Filing Date:
2014-02-05
Accepted Time:
2014-02-05 18:59:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-30 2,912,443 $0.00 2,912,443 No 4 C Indirect by Beacon Bioventures Fund II Limited Partnership
Common Stock Acquisiton 2014-01-30 172,797 $0.00 3,085,240 No 4 C Indirect by Beacon Bioventures Fund II Limited Partnership
Common Stock Acquisiton 2014-01-31 175,000 $21.00 3,260,240 No 4 P Indirect by Beacon Bioventures Fund II Limited Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect by Beacon Bioventures Fund II Limited Partnership
No 4 C Indirect by Beacon Bioventures Fund II Limited Partnership
No 4 P Indirect by Beacon Bioventures Fund II Limited Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2014-01-30 9,129,063 $0.00 2,912,443 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-01-30 541,634 $0.00 172,797 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. On January 30, 2014, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into Common Stock on a 3.1345-for-1 basis.